| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Christopher P. Acevedo | Chief Financial Officer | Jul 31, 2024 | |||
| Joacim Borg | Director | Jul 31, 2024 | |||
| John Ciccio | Director | Aug 2, 2024 | |||
| Colin Goddard | Director | Jul 31, 2024 | |||
| Robert Petit | Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated. | Jul 31, 2024 | |||
| Paul A. Romness | President and CEO, Director, 10%+ Owner | Jul 31, 2024 | |||
| Theodore F. Search | Director | Aug 2, 2024 | |||
| Avril McKean-Dieser | Director | Oct 28, 2024 | |||
| Olivier Jarry | Director | Oct 28, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|